Learning Objectives:

  1. Classify PKD1 and PKD2 genotypes which differ in disease progression and outcomes
  2. Differentiate among risk-stratified MIC 1A-1E classes
  3. Assess temporal change in radiomic features to predict kidney function decline
Session date: 
10/11/2024 - 12:00pm to 1:00pm CDT
Location: 
Via Zoom
5841 S. Maryland Ave
Chicago, IL 60637
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Linnea Kremer, PhD